Nicholas Iagulli, MD
Orthopaedic Surgery · N Richlnd Hls, TXNPI 1518123702
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,144 of the $2,897 with a category attached, or 74.0%. Stryker accounts for 84.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,584, 10.0 times the $159 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.
Across 20 payments — averaging $144.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Bone Support Inc.$183
- Smith+Nephew$124
- Johnson & Johnson$67
- Medical Device Business Services, Inc.$31
- Abbott$25
- plus $24 from 1 others
What the payments were for
- Travel & lodging$2,14474%
- Food & beverage$75326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 12 | $2,444 |
| Bone Support Inc. | 2 | $183 |
| Smith+Nephew | 1 | $124 |
| Johnson & Johnson | 2 | $67 |
| Medical Device Business Services, Inc. | 1 | $31 |
| Abbott | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,199
- CERAMENTBONE VOID FILLER$144
- Regeneten$124
How this compares
$2,897 in reported general payments places this provider in the 40th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 491 | $5,495 |
| Diclofenac Sodium | 157 | $3,832 |
| Meloxicam | 1,141 | $3,255 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 201 | $2,217 |
| Lidocaine | 33 | $2,107 |
| Tramadol Hcl | 144 | $1,154 |
| Naproxen | 72 | $605 |
| Cephalexin | 39 | $181 |
| Ibuprofen | 16 | $159 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in N Richlnd Hls
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.